Two Sigma Investments’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$591M Buy
9,411,231
+6,939,887
+281% +$555M 0.48% 27
2025
Q4
$236M Sell
2,471,344
-60,237
-2% -$5.91M 0.33% 36
2025
Q3
$247M Buy
2,531,581
+65,205
+3% +$6.75M 0.37% 29
2025
Q2
$265M Buy
2,466,376
+25,629
+1% +$2.59M 0.47% 17
2025
Q1
$246M Buy
2,440,747
+1,698,900
+229% +$171M 0.53% 13
2024
Q4
$66.3M Sell
741,847
-411,277
-36% -$36.2M 0.14% 168
2024
Q3
$96.6M Sell
1,153,124
-701,161
-38% -$55.3M 0.21% 112
2024
Q2
$143M Buy
1,854,285
+1,721,765
+1,299% +$126M 0.33% 70
2024
Q1
$9.08M Buy
132,520
+32,861
+33% +$2.11M 0.02% 687
2023
Q4
$5.76M Sell
99,659
-311,349
-76% -$16.6M 0.01% 912
2023
Q3
$21.7M Sell
411,008
-2,034,453
-83% -$107M 0.06% 362
2023
Q2
$132M Buy
2,445,461
+1,321,222
+118% +$69M 0.33% 70
2023
Q1
$56.2M Sell
1,124,239
-457,196
-29% -$21.5M 0.16% 148
2022
Q4
$73.2M Buy
1,581,435
+1,479,217
+1,447% +$64.1M 0.23% 108
2022
Q3
$3.96M Sell
102,218
-276,787
-73% -$11.1M 0.01% 841
2022
Q2
$14.1M Sell
379,005
-3,546,471
-90% -$144M 0.05% 412
2022
Q1
$174M Sell
3,925,476
-177,090
-4% -$7.67M 0.51% 27
2021
Q4
$174M Sell
4,102,566
-550,951
-12% -$23.2M 0.37% 51
2021
Q3
$202M Buy
4,653,517
+180,634
+4% +$7.99M 0.45% 31
2021
Q2
$191M Buy
4,472,883
+3,904,441
+687% +$164M 0.43% 36
2021
Q1
$22M Sell
568,442
-5,744,377
-91% -$217M 0.06% 394
2020
Q4
$227M Buy
+6,312,819
New +$228M 0.65% 18
2020
Q3
Sell
-522,829
Closed -$20.1M 3104
2020
Q2
$18.4M Sell
522,829
-783,666
-60% -$28.2M 0.09% 232
2020
Q1
$42.6M Sell
1,306,495
-261,060
-17% -$10.2M 0.35% 45
2019
Q4
$70.9M Buy
+1,567,555
New +$65.6M 0.21% 102
2019
Q2
Sell
-2,632,148
Closed -$101M 3334
2019
Q1
$101M Buy
2,632,148
+1,971,508
+298% +$75.3M 0.33% 50
2018
Q4
$23.3M Buy
+660,640
New +$24M 0.09% 295
2018
Q2
Sell
-2,867,336
Closed -$78.3M 3325
2018
Q1
$78.3M Sell
2,867,336
-835,203
-23% -$22.7M 0.26% 94
2017
Q4
$91.8M Buy
3,702,539
+1,635,881
+79% +$45.1M 0.3% 64
2017
Q3
$60.3M Sell
2,066,658
-470,512
-19% -$13M 0.21% 128
2017
Q2
$70.3M Sell
2,537,170
-1,491,286
-37% -$39.6M 0.25% 95
2017
Q1
$100M Sell
4,028,456
-968,456
-19% -$23.5M 0.34% 52
2016
Q4
$108M Sell
4,996,912
-854,412
-15% -$18.6M 0.41% 40
2016
Q3
$139M Buy
5,851,324
+4,287,966
+274% +$102M 0.5% 32
2016
Q2
$36.5M Buy
+1,563,358
New +$33.8M 0.16% 145
2015
Q3
Sell
-48,728
Closed -$862K 2225
2015
Q2
$862K Sell
48,728
-2,663,106
-98% -$47.6M ﹤0.01% 1751
2015
Q1
$48.1M Sell
2,711,834
-5,806,180
-68% -$91.8M 0.22% 118
2014
Q4
$113M Buy
8,518,014
+739,325
+10% +$9.45M 0.62% 16
2014
Q3
$91.9M Buy
7,778,689
+3,180,862
+69% +$40.1M 0.41% 57
2014
Q2
$58.7M Buy
4,597,827
+4,568,712
+15,692% +$59.4M 0.26% 87
2014
Q1
$394K Sell
29,115
-303,108
-91% -$3.98M ﹤0.01% 1571
2013
Q4
$3.99M Sell
332,223
-3,759,699
-92% -$44.4M 0.02% 713
2013
Q3
$48M Buy
4,091,922
+2,539,357
+164% +$27.5M 0.31% 80
2013
Q2
$14.4M Buy
+1,552,565
New +$13.2M 0.1% 271

Other funds holding BSX

Two Sigma Investments's BSX Position: Q1 2026 in Review

Two Sigma Investments increased its Boston Scientific (BSX) stake by 281% in Q1 2026, buying an estimated $555M and bringing the position to 9,411,231 shares worth $591M. The position accounts for 0.48% of the portfolio, ranked #27.

Two Sigma Investments first reported a position in BSX in Q2 2013 and has held it in 44 quarters since. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Two Sigma Investments held 9,411,231 shares of Boston Scientific worth $591M as of Q1 2026.
  • Two Sigma Investments bought 6,939,887 Boston Scientific shares in Q1 2026, an estimated $555M.
  • Boston Scientific made up 0.48% of Two Sigma Investments's portfolio in Q1 2026, its #27 holding.
  • Two Sigma Investments first reported a position in Boston Scientific in Q2 2013 and has held it in 44 quarters since.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.